Med Communications

In today’s competitive pharmaceutical landscape, engaging the right physician partner is essential to drive scientific strategy, shape research direction, and ensure impactful publication planning. But identifying, vetting, and engaging key opinion leaders (KOLs) requires more than a list of names—it demands deep scientific insight, strategic alignment, and flawless execution. That’s where Med Communications, Inc. can help. Our scientific communications team partners with medical affairs and scientific affairs leaders by supporting the full KOL engagement process, starting with intelligent recruitment and rigorous vetting. We identify the right voices for our clients through comprehensive analysis of publication records, clinical trial participation, and conference activity; we assess both scientific influence and strategic fit. Our approach ensures your team focuses on high-impact KOLs who align with your therapeutic goals and can meaningfully contribute to future research, publication planning, and long-term strategy. Once the right partners are identified, our team works to develop and execute high-value advisory boards. From agenda development to scientific pre-reads and discussion guides, our communications experts ensure each session delivers measurable outcomes. Whether you're refining your publication strategy or exploring future research directions our team ensures that every touchpoint with your KOLs is scientifically sound and strategically valuable. With Med Communications, you gain more than a vendor—you gain a partner who understands the complexity of medical affairs and the critical importance of KOL relationships. Our scientific communications team delivers the depth, structure, and clarity needed to maximize the impact of every physician consultation. Let us help you turn physician engagement into a strategic advantage. Connect with Med Communications today to learn how we can support your KOL engagement and advisory board success. To request a capabilities presentation, please contact us at 877-477-0977 or https://lnkd.in/eJUQt6C. #MedCommunicationsInc #KOL

A top 10 global pharmaceutical client observed a significant shift in the nature of MIRs across the Europe and Canada (EUCAN) region, with a growing number coming directly from people who are not healthcare professionals (non-HCPs) such as patients, caregivers, and members of the general public. In the first half of 2023 alone, non-HCPs accounted for nearly 15% of all inquiries, continuing a trend that had accelerated during the COVID-19 pandemic. This increase in non-HCP inquiries underscored a clear gap: existing response materials were primarily developed for HCPs and often too complex for a lay audience. Recognizing the importance of delivering accessible, compliant, and meaningful medical information to non-HCPs, a pilot project was started to create patient-friendly standard responses. Check out our newest case study to learn more about how Med Communications developed standard responses that delivered accurate, compliant answers in language easily understood by a lay audience: https://lnkd.in/eJB9HzZk. To request a capabilities presentation, please contact us at 877-477-0977 or https://lnkd.in/eJUQt6C. #MedCommunicationsInc #MedicalWriting #StandardResponses

During National Immunization Awareness Month, which is observed in the United States each August, we recognize the importance of vaccines. On-time vaccinations protect individuals from contracting infectious diseases, particularly the very young, the elderly, and people with compromised immune systems, and help slow or prevent the spread of disease throughout the community. Vaccines are a critical tool in safeguarding public health. Clear, accurate medical information support plays a key role in helping ensure patients receive the vaccines they need. Our contact center team has extensive experience and training in seasonal vaccine products. Med Communications proudly supports 60% of the United States’ influenza manufacturers and one-third of total influenza products on the market. During the 2009 H1N1 pandemic, Med Communications managed an increase of call volume greater than 1000% and our service levels never dipped under 90% of key performance indicators. We are extremely proficient in seasonal products and also support respiratory syncytial virus, travel vaccines, and childhood immunizations. Our team's expertise and dedication to quality service provide our clients with peace of mind as we enter vaccine season. For a capabilities presentation, please contact us today: 877-477-0977 or https://lnkd.in/eJUQt6C. #MedCommunications #NIAM #Vaccines

One of the challenges of providing global medical information support is that your customers’ business hours don’t always align with your own. Med Communications' contact center staff are available 24 hours per day, 365 days per year, in a range of countries across North America, South America, Europe, and Asia to help you meet customer needs. Customized hours of operation, including after-hours coverage, are available to suit client needs. We have Medical Information Specialists who speak local languages in multiple countries, and also offer translation services if needed. Omnichannel medical information capabilities offer broader access and assistance to clients. Our medical information contact center features a variety of contact methods, including: • Phone • Email • Medical Information request forms (MIRFs) • Live chat • Client website forms • Video scientific exchange • Searchable self-service online standard response database All of these methods integrate seamlessly with client systems. Med Communications ensures that your customers get the answers they need, in the format they prefer, just when they need it. To request a capabilities presentation, please contact us at 877-477-0977 or https://lnkd.in/eJUQt6C. #MedCommunicationsInc #Global #MedInfo

Pharmaceutical companies rely on medical writers to produce a range of informational and promotional documents for health care providers and consumers. These materials influence the safe and effective use of products, and thus affect overall patient health; they require writers and reviewers with a high level of expertise and a strong attention to detail. Examples of the types of projects these writers produce include: • Standard response documents (SRs) • Dossiers • Professional slide decks • Promotional materials • Conference materials • Scientific journal publications Med Communications’ Scientific Content team is highly experienced at collaborating with a wide variety of pharmaceutical clients to ensure that materials are compliant, comprehensive, and engaging. Our seasoned writers and reviewers, most of whom hold PharmDs or PhDs, have extensive experience in delivering high-quality, balanced scientific documents for the pharmaceutical, biotechnology, and healthcare industries. Our medical writers often become valued members of clients’ teams, leveraging their skills and expertise to ensure every document they work on is clear, concise, accurate, and engaging—and it shows in the feedback we receive. “I wanted to provide you with feedback on a Med Communications medical writer. Since she’s started, I’ve worked with her on standard response documents, medical information requests, and medical affairs materials. When she started, I was immediately impressed with the logic she applied to standard response content and medical information responses. She was a natural and I partly attributed that to clinical experience. As I worked with her on the update of the AMCP dossier, it was clear that she also had a strategic lens and was able to discern critical inclusions as well as practical solutions to lead and complete the update with as little impact to the team (time) as possible. She seems to naturally filter out unnecessary information, which is a skill that I have seen just about all new people struggle with, but it seems to come more naturally to her. More recently I have worked with her on a couple writing assets and I continue to be impressed. Without my prompting, she picked up on errors and improvements that even other seasoned writers would not pick up on. She not only has a keen attention to detail, but she also applies literal thinking to ensure proper interpretation of claims and statements. I’ve worked with and directly mentored many writers over the 20 years I’ve been here, and she is one of the finest. She jumps right into new things and isn’t afraid to try things on her own, speak up, disagree, and offer suggestions. I love working with her!” –Top 10 Pharma Company, Long-Term Client of Over 15 Years Contact us today for a capabilities presentation: 877-477-0977 or https://lnkd.in/gqruCztK. #MedCommunicationsInc #ScientificContent #MedicalWriter

Whether you are facing your first product launch or your 50th, Med Communications' team can support you during your launch journey. With hundreds of successful product launches under our belt, we have the knowledge and experience to assist and advise your company through all phases of the product life cycle. We received this feedback from a top 10 pharma company that we assisted with a new product launch: “During a recent product launch, our Senior Content Information Specialist lent her prior experience to the entire team, many of whom launched for the first time. She has kept us informed of the pieces coming through promotional review, [noted] areas of alignment that were important, and mentored and coached a colleague who had his first experience in taking a promotional asset through review—a complex process. She has worked additional hours, has flexed personal commitments to deliver for the business, and been a true collaborator and leader on our team.” Our expert medical writers, promotional review teams, and pharmacovigilance staff can set your organization up for success. In addition to ensuring that your promotional review materials are clear, concise, and accurate, they also provide valuable feedback and support, particularly for less experienced team members. We are not satisfied until we have exceeded expectations, and the feedback we receive reflects this. As one regulatory review client noted: "I just wanted to express my heartfelt awe at the partnership and collaboration exhibited by our Med Communications writer during a recent product launch. As a member of the promotional review team, having a strong, collaborative partner makes the job so much easier—and she went above and beyond. I rely on my Medical Information and Medical colleagues to ensure that the data within the promotional assets are correct and that the appropriate references to support the claims and presentation within the assets are identified. She was consistently on top of ensuring that the data were accurate—and where necessary, proposed alternative references and data to support claims and presentations. It was a truly collaborative experience, and I feel honored to have this writer as a teammate." Check out these case studies to see how we have handled previous client product launches: • Expedited Scale-Up To Support Global Launch of New Product: https://lnkd.in/geK7h4Bi • Expertise in Rare Disease Provides for Seamless Call Center Implementation and Product Launch: https://lnkd.in/dxbQfAuZ Contact us for a capabilities presentation: 877-477-0977 or https://lnkd.in/gqruCztK. #MedCommunicationsInc #ProductLaunch #ScientificCommunications

Pharmaceutical and biotech companies have important reasons to launch their medical information contact centers on time. Some have a date on which they expect regulatory approval for a new product or indication. Others have a date when their current vendor will stop providing service. To launch on time, pharmaceutical and biotech companies need to choose a vendor experienced across many contact center implementations and able to pass a client’s pre-qualification audit. A successful pre-qualification audit is critical to ensure that the vendor has the right people, training, processes, SOPs, and validated systems to securely and compliantly handle medical inquiries, adverse events, and product complaints. A vendor who cannot pass a client’s pre-qualification audit forces the client to start over with a new vendor. At Med Communications, we know this because some clients are with us after their previous would-be vendor could not pass the client’s pre-qualification audit. Med Communications has been audited many times by clients and has never failed a client audit. This 100% client audit approval is because Med Communications has intentionally designed our Contact Center operating model with a systematic focus on quality. A client audit of Med Communications Contact Center can be done on site or virtually, and covers the Med Communications staff, their backgrounds and training, Contact Center processes and SOPs, IT systems and security, quality system, data privacy (including GDPR compliance), business continuity, and more. A successful pre-qualification audit at Med Communications provides our clients with strong confidence and peace of mind that Med Communications is fully qualified and ready to deliver services as promised. To ensure a swift medical information contact center implementation, contact us today: 877-477-0977 or https://lnkd.in/eJUQt6C. #MedCommunicationsInc #ContactCenter #PrequalificationAudit

User-friendly, immediate access to medical information can increase healthcare professional (HCP) customer satisfaction. A self-service website for HCPs with a searchable online database of standard responses is a growing service for the pharmaceutical Medical Information area. The database allows HCPs to easily find medical information for a company’s products 24 hours a day, seven days a week. A searchable standard responses database can also increase contact center productivity and efficiency and reduce costs associated with handling various medical information inquiries. Giving HCPs the ability to find the answers to more simple searches frees up contact center employees to focus on more complex and involved medical information inquiries. While some pharmaceutical companies work with their IT teams to build, license, implement, and integrate their software and systems in delivery of a searchable standard response database for their HCP customers, our outsourcing partnership can provide seamless solutions that are more cost effective. To best serve our clients, Med Communications works in tandem with leading technology experts to create, launch, and support searchable standard response databases for our clients and their HCPs. Our partners use gold standard technology to provide an intuitive customer experience in searchable databases for medical information contact center agents and a customer relationship management system for tracking customer medical information inquiries. Med Communications coordinates the technical work for our contact center clients, including creation, launch, and support of the searchable online database. The client chooses which of the standard responses will be searchable online and determines the look and feel of the customer interface website. Implementation is done in real time whenever an approved new or updated standard response is available. Outsourcing a searchable standard response database to a trusted and reliable partner allows pharmaceutical companies to focus on their most critical activities. If your company could benefit from a searchable standard response database for HCP customers, please contact us for a capabilities presentation: 877-477-0977 or https://lnkd.in/gqruCztK. #MedCommunications #ScientificCommunications #MedInfo #ContactCenter

AMCP formulary dossiers provide managed care organizations and health care decision makers with the information they need for formulary and medical policy coverage or reimbursement considerations. These dossiers include comprehensive coverage of US clinical and economic evidence for new and existing medical drugs, tests, or devices, as well as a clear, concise view of the clinical, safety, and economic data. Dossiers must contain the most recent, relevant, scientifically accurate and balanced information about pharmaceutical products. Once a dossier has been compiled and approved, it may be reviewed and updated when there are significant changes to the content, such as changes to the prescribing information, new clinical or economic evidence, new safety data, updates to patient populations, and demonstrations of real-world or long-term effectiveness. These complex documents are time consuming to create and maintain, and require writers with a high level of both scientific and writing expertise. At Med Communications, we understand the importance of effective communication in order to facilitate formulary additions and optimize reimbursement. We have extensive experience developing and maintaining valuable and strategic product dossiers across various therapeutic areas. Our team of highly experienced and knowledgeable scientific writers and reviewers can present the value of your product relative to existing alternatives by improving the span, quality, and relevance of information in the dossier to meet your needs. For more information on how Med Communications can help you create and maintain AMCP formulary dossiers, contact us: 877-477-0977 or https://lnkd.in/gqruCztK. #MedCommunicationsInc #AMCPDossier #ScientificCommunications

Med Communications has added a new department: Regulatory Writing. This department will support clients' regulatory needs by providing high-quality writing, project management, and consulting for projects like clinical study reports and full submissions. Leading this team is our newest director, Ann Winter-Vann. Ann received her PhD in Molecular Cancer Biology from Duke University, where she was supported by a fellowship from the Howard Hughes Medical Institute. Following a postdoc with the Department of Pharmacology at the University of North Carolina at Chapel Hill, Ann transitioned into regulatory writing, where she supported a variety of clients that ranged from biotech start-ups to several of the largest pharmaceutical companies. Ann's therapeutic areas of expertise include oncology (including CAR-T), gastroenterology, ophthalmology, respiratory, immunology, and rare disease. With more than 17 years of experience in regulatory writing, Ann has authored clinical research and regulatory documents for the US Food and Drug Administration, the European Medicines Agency, and submissions to China. Her document experience includes protocols, clinical study reports, submission documents (clinical summaries, integrated summaries, clinical overviews, assessment aids, and responses to agency questions), Investigator's Brochures, and briefing packages, and she is an advocate for lean writing principles. In her previous position as Director of Medical Writing Services at Whitsell Innovations, Inc., Ann led a department of 50 managers, medical writers, quality control reviewers, and publishers. In 2021, Ann received the DIA Medical Affairs and Scientific Communications Excellence in Service Award. Ann is a Fellow and Past President of the American Medical Writers Association. Med Communications is grateful to have someone with Ann's background and expertise helping to establish this exciting new service area. We are confident that she will build a team that upholds Med Communications' high standards for quality service and customer connection. Contact her today at 877-202-3759 or https://lnkd.in/eJUQt6C.